Cargando…
Intake of 25-Hydroxyvitamin D(3) May Reduce the Severity of Upper Respiratory Tract Infection: Post hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study
To evaluate the effects of 25-hydroxyvitamin D(3) (25OHD) on symptoms at the onset of the upper respiratory tract infection (URTI) in subjects with insufficient or deficient serum 25-hydroxyvitamin D levels, we conducted a post hoc analysis of data from a randomized, placebo-controlled study; the su...
Autores principales: | Shimizu, Yoshiki, Ito, Yukihiko, Uotsu, Nobuo, Yui, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764240/ https://www.ncbi.nlm.nih.gov/pubmed/33302570 http://dx.doi.org/10.3390/nu12123769 |
Ejemplares similares
-
Intake of 25-hydroxyvitamin D3 reduces duration and severity of upper respiratory tract infection: A randomized, double-blind, placebo-controlled, parallel group comparison study
por: Shimizu, Yoshiki, et al.
Publicado: (2017) -
Pharmacokinetics of a Single Intake of a Self-Emulsifying Drug Delivery System Containing the Triglyceride Form of DHA: A Randomized, Double-Blinded, Crossover Study
por: Hayashida, Mariko, et al.
Publicado: (2022) -
Low Serum 25-Hydroxyvitamin D Level and Risk of Upper Respiratory Tract Infection in Children and Adolescents
por: Science, Michelle, et al.
Publicado: (2013) -
Dietary Calcium Intake and Hypertension: Importance of Serum Concentrations of 25-Hydroxyvitamin D
por: Nakamura, Haruki, et al.
Publicado: (2019) -
The dietary constituent resveratrol suppresses nociceptive neurotransmission via the NMDA receptor
por: Takehana, Shiori, et al.
Publicado: (2017)